Literature DB >> 2285688

A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens.

P McKenna1, S J Morgan, R C Bosanquet, M F Laker.   

Abstract

The cholestanol content of a cataractous lens nucleus from a patient with cerebrotendinous xanthomatosis (CTX) was quantified by gas chromatography-mass spectrometry and found to be 0.27 micrograms per mg freeze-dried lens tissue. The cholestanol-cholesterol ratio of 1.7% in the lens nucleus was similar to that in the serum of the CTX patient. The cholestanol content and cholestanol-cholesterol ratio in the CTX lens were approximately four-fold and six-fold greater respectively than the mean levels found in three senile cataractous lens nuclei analysed simultaneously for comparative purposes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285688      PMCID: PMC1042235          DOI: 10.1136/bjo.74.10.629

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  Myotonia induced by diazacholesterol: increased (Na+ + K+)-ATPase activity of erythrocyte ghosts and development of cataracts.

Authors:  J B Peter; R M Andiman; R L Bowman; T Nagatomo
Journal:  Exp Neurol       Date:  1973-12       Impact factor: 5.330

3.  Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism.

Authors:  G Salen
Journal:  Ann Intern Med       Date:  1971-12       Impact factor: 25.391

4.  Cerebrotendinous xanthomatosis. The storage of cholestanol within the nervous system.

Authors:  J H Menkes; J R Schimschock; P D Swanson
Journal:  Arch Neurol       Date:  1968-07

5.  The ultrastructure of lens and iris in cerebrotendinous xanthomatosis.

Authors:  J H Seland; J E Slagsvold
Journal:  Acta Ophthalmol (Copenh)       Date:  1977-04

6.  Quantitative determination of cholestanol in plasma with mass fragmentography. Biochemical diagnosis of cerebrotendinous xanthomatosis.

Authors:  Y Seyama; K Ichikawa; T Yamakawa
Journal:  J Biochem       Date:  1976-08       Impact factor: 3.387

7.  Cholesterol and phospholipids in protein fractions of human lens and senile cataract.

Authors:  E Cotlier; Y Obara; B Toftness
Journal:  Biochim Biophys Acta       Date:  1978-08-25

8.  Determination of hepatic cholesterol 7alpha-hydroxylase activity in man.

Authors:  F J Schmitz; F J McDonald
Journal:  J Lipid Res       Date:  1974-03       Impact factor: 5.922

9.  The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.

Authors:  G Salen; S M Grundy
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

10.  A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain.

Authors:  T Setoguchi; G Salen; G S Tint; E H Mosbach
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

View more
  2 in total

1.  Cerebrotendinous xanthomatosis: heterogeneity of clinical phenotype with evidence of previously undescribed ophthalmological findings.

Authors:  M T Dotti; A Rufa; A Federico
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

2.  Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.

Authors:  Shingo Koyama; Yoshiki Sekijima; Masatsune Ogura; Mika Hori; Kota Matsuki; Takashi Miida; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-05-08       Impact factor: 4.928

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.